Subscribe To
Betterlife pharma says betr-001 drug candidate featured in drug discovery & development article
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an article titled “Non-hallucinogenic LSD derivative reduces depression symptoms in...
March 29, 2023, 9:31 am
Synlogic, inc. (sybx) reports q4 loss, misses revenue estimates
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for t...
March 29, 2023, 9:13 am
Winnebago (wgo) to buy lithionics to rev up its e-mobility game
The acquisition of Lithionics will improve Winnebago's (WGO) supply chain and boost the company's technologic<...
March 29, 2023, 9:13 am
Why is logicmark (lgmk) stock up 31% today?
logicMark (NASDAQ: LGMK ) stock is on the rise Wednesday following the release of its earnings report f...
March 29, 2023, 8:23 am
Somalogic, inc. (slgc) q4 2022 earnings call transcript
Somalogic, Inc. (NASDAQ:SLGC ) Q4 2022 Earnings Conference Call March 27, 2023 4:30 PM ET Company Parti...
March 29, 2023, 12:59 am
Somalogic, inc. (slgc) reports q4 loss, tops revenue estimates
Somalogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the...
March 28, 2023, 7:04 pm
logicmark, inc. (lgmk) q4 2022 earnings call transcript
logicMark, Inc. (NASDAQ:LGMK ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Parti...
March 28, 2023, 6:42 pm
Strata skin sciences reschedules fourth quarter 2022 conference call and webcast to friday, march 31, 2023
HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, comm...
March 28, 2023, 4:01 pm
International flavors (iff) encapsulates vegan supplements
International Flavors (IFF) creates a technological breakthrough with its leading patented SeaGel techn...
March 28, 2023, 12:15 pm
Biolife solutions: capitalizing on the future of biopreservation
BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for bio...
March 28, 2023, 12:08 pm
Should investors hold on to avalonbay (avb) stock for now?
Healthy demand for residential properties, strategic buyouts and technological innovations bode well fo...
March 28, 2023, 10:43 am
Anglo asian mining reckons garadag potential at 300,000 tonnes of copper
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) has confirmed that it has the potential to produce over 300,000 tonnes of copper from its Garadag porphyry...
March 27, 2023, 3:14 am
Bhp: no end in sight for the good times
Returns remain superior, with 29% ROCE generated in H1 FY 2022/23, and returns to shareholders reaching 38 billion US dollars over the past 3 years. T...
March 26, 2023, 3:07 am
3 stocks you can keep forever
Coca-Cola has been paying dividends and making its investors rich for over 100 years. With a broad mix of techno...
March 25, 2023, 9:15 am
Lightwave logic: 2023 will be decisive
2023 will be a decisive year for LWLG, starting with the results from foundries but also with the situation for VC markets and early-stage investments...
March 25, 2023, 5:16 am
Heritage financial corporation: bright earnings outlook with manageable risk
Margin expansion will slow down due to the recent deterioration of the loan mix. Further, the deposit cost's rate sensitivity will likely increase, wh...
March 25, 2023, 4:00 am
Block out the noise: the hindenburg report
Hindenburg's estimate of downside risk is based on poor logic. The report focuses on only 1 of Block's ...
March 25, 2023, 2:34 am
Iovance biotherapeutics completes license application submission for advanced melanoma therapy; shares rally
Biotech cancer-treatment developer Iovance Biotherapeutics Inc. IOVA, -3.83% on Friday said it had completed its rolling bio...
March 24, 2023, 7:55 pm
Theriva biologics to reschedule conference call and webcast to discuss fourth quarter and full-year 2022 operational highlights and financial results
Conference call to be held on Thursday, March 30 at 8:30 a.m. ET Conference call to be held on Thursday, March 30 at 8:30 a.m. ET...
March 24, 2023, 4:05 pm
Aptose biosciences announces q4 and fy 2022 results
Aptose Biosciences (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to tr...
March 24, 2023, 2:20 pm